FDA Patient Experience Data Guidance Needs Labeling Details, Drugmakers Say

In comments on the first of four FDA patient experience data guidances, Allergan and Roche urged the agency to add more details on data that can be used in labeling.
Source: Drug Industry Daily

No announcement available or all announcement expired.